Purification and refolding of the recombinant subunit B protein of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Purpose: Aggregatibacter actinomycetemcomitans is associated with localized aggressive periodontitis. It produces cytolethal distending toxin (CDT), which induces cell cycle arrest in the G2/M phase. The CDT holotoxin is composed of CdtA, CdtB, and CdtC. CdtB has structural homology to human DNase I and is an active component of the CDT complex acting as a DNase. In particular, the pattern homology seen in the CdtB subunit has been associated with specific DNase I residues involved in enzyme catalysis, DNA binding, and metal ion binding. So, to study the functions and regulation of recombinant CdtB, we made up a quantity of functional recombinant CdtB and tested it in relation to the metal ion effect. Materials and Methods: We constructed the pET28a-cdtB plasmid from A. actinomycetemcomitans Y4 by genomic DNA PCR and expressed it in the BL21 (DE3) Escherichia coli system. We obtained the functional recombinant CdtB by the refolding system using the dialysis method and then analyzed the DNase activity and investigated the metal ion effect from plasmid digestion. Results: The recombinant CdtB subunit was expressed as the inclusion bodies. We were able to obtain functional recombinant CdtB subunit using refolding system. We confirmed that our refolded recombinant CdtB had DNase activity and was influenced by the metal ions Mg2+ and Ca2+. Conclusion: We suggest that the factors influencing recombinant CdtB may contribute to CDT associated diseases, such as periodontitis, endocarditic, meningitis, and osteomyelitis. (J Korean Acad Periodontol 2008;38:343-354)
Abstract
Purpose: Aggregatibacter actinomycetemcomitans is associated with localized aggressive periodontitis. It produces cytolethal distending toxin (CDT), which induces cell cycle arrest in the G2/M phase. The CDT holotoxin is composed of CdtA, CdtB, and CdtC. CdtB has structural homology to human DNase I and is an active component of the CDT complex acting as a DNase. In particular, the pattern homology seen in the CdtB subunit has been associated with specific DNase I residues involved in enzyme catalysis, DNA binding, and metal ion binding. So, to study the functions and regulation of recombinant CdtB, we made up a quantity of functional recombinant CdtB and tested it in relation to the metal ion effect. Materials and Methods: We constructed the pET28a-cdtB plasmid from A. actinomycetemcomitans Y4 by genomic DNA PCR and expressed it in the BL21 (DE3) Escherichia coli system. We obtained the functional recombinant CdtB by the refolding system using the dialysis method and then analyzed the DNase activity and investigated the metal ion effect from plasmid digestion. Results: The recombinant CdtB subunit was expressed as the inclusion bodies. We were able to obtain functional recombinant CdtB subunit using refolding system. We confirmed that our refolded recombinant CdtB had DNase activity and was influenced by the metal ions Mg2+ and Ca2+. Conclusion: We suggest that the factors influencing recombinant CdtB may contribute to CDT associated diseases, such as periodontitis, endocarditic, meningitis, and osteomyelitis. (J Korean Acad Periodontol 2008;38:343-354)
참고문헌 (27)
- Baehni P, "Interaction of inflammatory cells and oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived gram-negative microorganism", Infect Immun, 24, pp.233~243 (1979)
- Brandes A, "Focal meningoencephalitis as initial manifestation of Actinomyces actinomycetemcomitans endocarditis", Med Klin, 88, pp.88~90 (1993)
- Helgeland K, "Cell cycle-specific growth inhibitory effect on human gingival fibroblasts of a toxin isolated from the culture medium of Actinomyces actinomycetemcomitans", J Periodontal Res, 28, pp.161~165 (1993)
- Nakano K, "Detection and serotype distribution of Aggregatibacter actinomycetemcomitans in cardiovascular specimens from Japanese patients", Oral Microbiol Immunol, 22, pp.136~139 (2007)
- Paturel L, "Actinomyces actinomycetemcomitans endocarditis", Clin Microbiol Infect, 10, pp.98~118 (2004)
- Shenker BJ, "Immune suppression induced by Actinomyces actinomycetemcomitans: effects on immunoglobulin production by human B cells", Infect Immun, 58, pp.3856~3862 (1990)
- Slots J, "Actinomyces actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation", Infect Immun, 29, pp.1013~1020 (1980)
- Sugai M, "The cell cycle-specific growth-inhibitory factor produced by Actinomyces actinomycetemcomitans is a cytolethal distending toxin", Infect Immun, 66(5008)통권 : 5019 (1998)
- Fives-Taylor P, "Characteristics of Actinomyces actinomycetemcomitans invasion of and adhesion to cultured epithelial cells", Adv Dent Res, 9, pp.55~62 (1995)
- Shenker BJ, "Inhibition of fibroblast proliferation by Actinomyces actinomycetemcomitans", Infect Immun, 38, pp.986~992 (1982)
- Shenker BJ, "Actinomyces actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells", J Immunol, 162, pp.4773~4780 (1999)
- Lara-Tejero M, "Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions", Trends Microbiol, 10, pp.147~152 (2002)
- Nesic D, "Assembly and function of a bacterial genotoxin", Nature, 429, pp.429~433 (2004)
- Nishikubo S, "An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus", J Biol Chem, 278, pp.50671~50681 (2003)
- Avenaud P, "Expression and activity of the cytolethal distending toxin of Helicobacter hepaticus", Biochem Biophys Res Commun, 318, pp.739~745 (2004)
- Elwell CA, "DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest", Mol Microbiol, 37, pp.952~963 (2000)
- Love JD, "The relationship between human serum and human pancreatic DNase I", J Biol Chem, 254, pp.12588~12594 (1979)
- Saiki K, "Reconstitution and purification of cytolethal distending toxin of Actinomyces actinomycetemcomitans", Microbiol Immunol, 45, pp.497~506 (2001)
- Middelberg AP, "Preparative protein refolding", Trends Biotechnol, 20, pp.437~443 (2002)
- Singh SM, "Solubilization and refolding of bacterial inclusion body proteins", J Biosci Bioeng, 99, pp.303~310 (2005)
- Shenker BJ, "Actinomyces actinomycetemcomitans cytolethal distending toxin (Cdt): evidence that the holotoxin is composed of three subunits: CdtA, CdtB, and CdtC", J Immunol, 172, pp.410~417 (2004)
- Wising C, "Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model", Microb Pathog, 33, pp.49~62 (2002)
- Akifusa S, "Recombinant Actinomyces actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis", Infect Immun, 69, pp.5925~5930 (2001)
- Shenker BJ, "Induction of apoptosis in human T cells by Actinomyces actinomycetemcomitans cytolethal distending toxin is a consequence of G2 arrest of the cell cycle", J Immunol, 167, pp.435~441 (2001)
- Scott DA, "Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin", Infect Immun, 62, pp.244~251 (1994)
- Evans SJ, "Site-directed mutagenesis of phosphate-contacting amino acids of bovine pancreatic deoxyribonuclease I", Biochemistry, 38, pp.3902~3909 (1999)
- Suck D, "DNA recognition by DNase I", J Mol Recognit, 7, pp.65~70 (1994)